1. Home
  2. TRAW vs GSIW Comparison

TRAW vs GSIW Comparison

Compare TRAW & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRAW
  • GSIW
  • Stock Information
  • Founded
  • TRAW 1998
  • GSIW 2016
  • Country
  • TRAW United States
  • GSIW Hong Kong
  • Employees
  • TRAW N/A
  • GSIW N/A
  • Industry
  • TRAW
  • GSIW
  • Sector
  • TRAW
  • GSIW
  • Exchange
  • TRAW NYSE
  • GSIW Nasdaq
  • Market Cap
  • TRAW 7.8M
  • GSIW 8.3M
  • IPO Year
  • TRAW 2013
  • GSIW 2023
  • Fundamental
  • Price
  • TRAW $1.19
  • GSIW $0.73
  • Analyst Decision
  • TRAW
  • GSIW
  • Analyst Count
  • TRAW 0
  • GSIW 0
  • Target Price
  • TRAW N/A
  • GSIW N/A
  • AVG Volume (30 Days)
  • TRAW 155.0K
  • GSIW 1.9M
  • Earning Date
  • TRAW 05-15-2025
  • GSIW 12-31-2024
  • Dividend Yield
  • TRAW N/A
  • GSIW N/A
  • EPS Growth
  • TRAW N/A
  • GSIW N/A
  • EPS
  • TRAW N/A
  • GSIW N/A
  • Revenue
  • TRAW $227,000.00
  • GSIW $1,313,795.00
  • Revenue This Year
  • TRAW $3.81
  • GSIW N/A
  • Revenue Next Year
  • TRAW $30.43
  • GSIW N/A
  • P/E Ratio
  • TRAW N/A
  • GSIW N/A
  • Revenue Growth
  • TRAW 0.44
  • GSIW N/A
  • 52 Week Low
  • TRAW $1.32
  • GSIW $0.35
  • 52 Week High
  • TRAW $19.44
  • GSIW $12.30
  • Technical
  • Relative Strength Index (RSI)
  • TRAW 31.22
  • GSIW 68.55
  • Support Level
  • TRAW $0.97
  • GSIW $0.43
  • Resistance Level
  • TRAW $1.54
  • GSIW $1.03
  • Average True Range (ATR)
  • TRAW 0.19
  • GSIW 0.10
  • MACD
  • TRAW 0.02
  • GSIW 0.04
  • Stochastic Oscillator
  • TRAW 34.92
  • GSIW 54.60

About TRAW TRAWS PHARMA INC

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

Share on Social Networks: